Quantification of white matter injury following neonatal stroke with serial DTI. 2013

Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.

BACKGROUND Diffusion tensor imaging (DTI) can be used to predict outcome following perinatal arterial ischemic stroke (PAIS), although little is known about white matter changes over time. METHODS Infants with PAIS were serially scanned in the neonatal period (n = 15), at 3 mo (n = 16), and at 24 mo (n = 8). Fractional anisotropy (FA) values in five regions of interest (anterior and posterior limb of the internal capsule, corpus callosum, optic radiation, and posterior thalamic radiation) were obtained and compared with FA values of healthy controls and neurodevelopmental outcome. RESULTS In the neonatal period, no differences in FA values were found. At 3 mo, the six infants who ultimately developed motor deficits showed lower FA values in all affected regions. Four infants developed a visual field defect and showed lower FA values in the affected optic radiation at 3 mo (0.22 vs. 0.29; P = 0.03). Finally, a correlation between FA values of the corpus callosum at 3 mo and the Griffiths developmental quotients was found (r = 0.66; P = 0.03). At 24 mo, a similar pattern was observed. CONCLUSIONS Neonatal FA measurements may underestimate the extent of injury following PAIS. FA measurements at 3 mo could be considered a more reliable predictor of neurodevelopmental outcome and correlate with DTI findings at 24 mo.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014794 Visual Fields The total area or space visible in a person's peripheral vision with the eye looking straightforward. Field, Visual,Fields, Visual,Visual Field
D056324 Diffusion Tensor Imaging The use of diffusion ANISOTROPY data from diffusion magnetic resonance imaging results to construct images based on the direction of the faster diffusing molecules. Diffusion Tractography,DTI MRI,Diffusion Tensor MRI,Diffusion Tensor Magnetic Resonance Imaging,Diffusion Tensor MRIs,Imaging, Diffusion Tensor,MRI, Diffusion Tensor,Tractography, Diffusion
D056784 Leukoencephalopathies Any of various diseases affecting the white matter of the central nervous system. Childhood Ataxia with Diffuse Central Nervous System Hypomyelination,Leukoencephalopathy,Leukoencephalopathy with Vanishing White Matter,Vanishing White Matter Disease,CACH Syndrome,CACH VWM Syndrome,Childhood Ataxia with Central Nervous System Hypomyelination,Childhood Ataxia with Central Nervous System Hypomyelinization,Cree Leukoencephalopathy,Myelinosis Centralis Diffusa,Vanishing White Matter Leukodystrophy,White Matter Diseases,CACH Syndromes,CACH VWM Syndromes,Centralis Diffusa, Myelinosis,Cree Leukoencephalopathies,Diffusa, Myelinosis Centralis,Diffusas, Myelinosis Centralis,Leukoencephalopathy, Cree,Myelinosis Centralis Diffusas,Syndrome, CACH VWM,VWM Syndrome, CACH,White Matter Disease
D020521 Stroke A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) Apoplexy,Cerebral Stroke,Cerebrovascular Accident,Cerebrovascular Apoplexy,Vascular Accident, Brain,CVA (Cerebrovascular Accident),Cerebrovascular Accident, Acute,Cerebrovascular Stroke,Stroke, Acute,Acute Cerebrovascular Accident,Acute Cerebrovascular Accidents,Acute Stroke,Acute Strokes,Apoplexy, Cerebrovascular,Brain Vascular Accident,Brain Vascular Accidents,CVAs (Cerebrovascular Accident),Cerebral Strokes,Cerebrovascular Accidents,Cerebrovascular Accidents, Acute,Cerebrovascular Strokes,Stroke, Cerebral,Stroke, Cerebrovascular,Strokes,Strokes, Acute,Strokes, Cerebral,Strokes, Cerebrovascular,Vascular Accidents, Brain

Related Publications

Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
April 2017, Neurology,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
February 2011, Experimental brain research,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
May 2008, Brain & development,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
January 2016, Journal of leukocyte biology,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
June 2015, Pediatric cardiology,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
June 2016, Progress in neurobiology,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
April 2013, Stroke,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
January 2009, Pediatric research,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
October 2020, Scientific reports,
Niek E van der Aa, and Frances J Northington, and Brian S Stone, and Floris Groenendaal, and Manon J N L Benders, and Giorgio Porro, and Shoko Yoshida, and Susumu Mori, and Linda S de Vries, and Jiangyang Zhang
March 2000, Neuroscience letters,
Copied contents to your clipboard!